Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplant
.
2020 Jul;55(7):1457-1459.
doi: 10.1038/s41409-019-0760-5.
Epub 2019 Nov 26.
Authors
Lars K Gjærde
1
2
,
Niels S Andersen
3
,
Lone S Friis
3
,
Brian Kornblit
3
,
Søren L Petersen
3
,
Ida Schjødt
3
,
Sisse R Ostrowski
4
5
,
Henrik Sengeløv
3
4
Affiliations
1
Bone Marrow Transplant Unit, Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
[email protected]
.
2
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
[email protected]
.
3
Bone Marrow Transplant Unit, Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
4
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
5
Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
PMID:
31772337
DOI:
10.1038/s41409-019-0760-5
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Graft vs Host Disease* / etiology
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Transplantation, Homologous
Vitamin A
Substances
Vitamin A
Grants and funding
DNRF126/Danmarks Grundforskningsfond (Danish National Research Foundation)/International